Alzheimer’s Disease Neuroimaging Initiative

4453 Total Publications

Year	Title	Author	Journal
2013	Discriminative Feature Selection for Uncertain Graph Classification.	Kong X, Yu P, Wang X, Ragin A.	Journal arXiv Prepr;
2013	Critical ages in the life course of the adult brain: nonlinear subcortical aging.	Fjell, A. M., Westlye, L. T., Grydeland, H., Amlien, I., Espeseth, T., Reinvang, I., … Walhovd, K. B.	Journal Neurobiology of Aging;
2013	How early can we predict Alzheimer‚Äôs disease using computational anatomy?	Adaszewski, S., Dukart, J., Kherif, F., Frackowiak, R., & Draganski, B.	Journal Neurobiology of Aging;
2013	The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-Œµ4 carriers	Benitez, BA, Karch, CM, Cai, Y, Jin, SC, Cooper, B, Carrell, D, Bertelsen, S, Chibnik, L, Schneider, JA, Bennett, DA, Fagan, AM, Holtzman, D, Morris, JC, Goate, AM and Cruchaga, C	Journal PLoS Genet;
2013	Plasma proteomics for the identification of Alzheimer disease	Guo, LH, Alexopoulos, P, Wagenpfeil, S, Kurz, A and Perneczky, R	Journal Alzheimer Dis Assoc Disord;
2013	Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods.	Hobart, J., Cano, S., Posner, H., Selnes, O., Stern, Y., Thomas, R., & Zajicek, J.	Journal Alzheimer's and Dementia;
2013	A Sparse Structure Learning Algorithm for Gaussian Bayesian Network Identification from High-Dimensional Data	Huang, S, Li, J, Ye, JP, Fleisher, A, Chen, KW, Wu, T, Reiman, E and Alzheimers Dis Neuroimaging, I	Journal Ieee Transactions on Pattern Analysis and Machine Intelligence;
2013	Standardization of analysis sets for reporting results from ADNI MRI data.	Wyman, B. T., Harvey, D. J., Crawford, K., Bernstein, M. a, Carmichael, O., Cole, P. E., ‚Ä¶ Jack, C. R.	Journal Alzheimer's and Dementia;
2013	Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.	Nettiksimmons, J., Beckett, L., Schwarz, C., Carmichael, O., Fletcher, E., & Decarli, C.	Journal Psychology and Aging;
2013	CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer‚Äôs disease.	Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.	Journal Acta Neuropathologica;